AVITA MEDICAL INC (RCEL) Institutional Ownership
None of the superinvestors we track currently report AVITA MEDICAL INC (RCEL) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in AVITA MEDICAL INC (RCEL), this page will show institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q1 2024 | 1 | $378 | 23,600 |
| Q4 2023 | 1 | $505 | 36,800 |
| Q3 2023 | 1 | $1,040 | 71,200 |
| Q2 2023 | 1 | $1,701 | 100,000 |
| Q1 2023 | 1 | $2,966 | 212,336 |
| Q4 2022 | 1 | $1,428 | 216,312 |
| Q3 2022 | 1 | $1,257 | 238,580 |
| Q2 2022 | 1 | $1,555 | 327,280 |
| Q1 2022 | 1 | $1,826 | 215,280 |
| Q4 2020 | 1 | $3,065 | 164,980 |
| Q3 2020 | 1 | $1,916 | 76,172 |
| Q2 2020 | 1 | $2,782 | 91,100 |
Related RCEL Institutional Insights:
- RCEL Institutional Ownership & Insiders Activity
- RCEL Institutional Ownership & 13F Activity
- RCEL Top Institutional Shareholders
- RCEL Institutional Buying Activity
- RCEL Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- RCEL Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings